olamufloxacin

Known as: (-)-5-Amino-7-((S)-7-Amino-5-Azaspiro(2,4)Hept-5-yl)-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methyl-4-Oxo-3-Quinolinecarboxylic Acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
012320002017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
In the context of drug discovery, novel spirocyclic pyrrolidines have been synthesized in two steps from common three- to seven… (More)
Is this relevant?
2006
2006
This study described distribution characteristics of olamufloxacin (HSR-903) in lung epithelial lining fluid (ELF) and alveolar… (More)
Is this relevant?
2004
2003
2003
This study was performed to characterize the protonation equilibrium at the molecular level and pH-dependent lipophilicity of… (More)
Is this relevant?
2003
2003
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in vitro and in vivo. The… (More)
Is this relevant?
2003
2003
OBJECTIVES To determine the susceptibility of southern African strains of Yersinia pestis to novel as well as conventional… (More)
  • table 1
Is this relevant?
2001
2001
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin… (More)
Is this relevant?
Review
2000
Review
2000
Hokuriku is developing olamufloxacin, a quinolone antibiotic that inhibits DNA gyrase, for the potential treatment of various… (More)
Is this relevant?